Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis

Interleukin (IL)-17 and tumor necrosis factor-alpha (TNF)-α are key players in psoriatic arthritis (PsA) pathogenesis. While both cytokines can be therapeutically targeted with beneficial clinical outcome, it is unclear whether inhibiting one cytokine will affect the other at sites of inflammation....

Descripción completa

Detalles Bibliográficos
Autores principales: Bolt, Janne W., van Kuijk, Arno W., Teunissen, Marcel B. M., van der Coelen, Dennis, Aarrass, Saïda, Gerlag, Daniëlle M., Tak, Paul P., van de Sande, Marleen G., Lebre, Maria C., van Baarsen, Lisa G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869729/
https://www.ncbi.nlm.nih.gov/pubmed/35203534
http://dx.doi.org/10.3390/biomedicines10020324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869729/
https://www.ncbi.nlm.nih.gov/pubmed/35203534
http://dx.doi.org/10.3390/biomedicines10020324

Ejemplares similares